Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NCI scientists initiate testing of thalidomide in colorectal cancer patients

Aug. 10, 1999

No Comments

SCRAS team evaluates topoisomerase inhibitors for cancer indications

Aug. 10, 1999

No Comments

Phase Ia results reported for Cell Pathways' novel SAAND

Aug. 10, 1999

No Comments

Takeda scientists synthesize and evaluate GnRH antagonists

Aug. 9, 1999

No Comments

Novel cell adhesion inhibitors in the pipeline at Roche

Aug. 9, 1999

No Comments

Introgen Therapeutics obtains worldwide rights to mda7 gene from Corixa

Aug. 9, 1999

No Comments

Fournier returns European rights for tgDCC-E1A to Targeted Genetics

Aug. 9, 1999

No Comments

ADIR discloses alkaloid derivatives with improved potency and solubility

Aug. 6, 1999

No Comments

Liposome initiates clinical trial of Evacet in combination with Herceptin

Aug. 6, 1999

No Comments

Combination immunotherapy kills melanoma in mice

Aug. 6, 1999

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cancer
RSS

NCI scientists initiate testing of thalidomide in colorectal cancer patients

SCRAS team evaluates topoisomerase inhibitors for cancer indications

Phase Ia results reported for Cell Pathways' novel SAAND

Takeda scientists synthesize and evaluate GnRH antagonists

Novel cell adhesion inhibitors in the pipeline at Roche

Introgen Therapeutics obtains worldwide rights to mda7 gene from Corixa

Fournier returns European rights for tgDCC-E1A to Targeted Genetics

ADIR discloses alkaloid derivatives with improved potency and solubility

Liposome initiates clinical trial of Evacet in combination with Herceptin

Combination immunotherapy kills melanoma in mice

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Cancer RSS

Cancer
RSS